Viewing Study NCT05797168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-05-17 @ 10:05 AM
Study NCT ID: NCT05797168
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Lung Adenocarcinoma View
None Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ADC View
None PARP inhibitor View
None AZD5335 View
None AZD5305 View
None Saruparib View
None Bevacizumab View
None Carboplatin View
None AZD9574 View
None Ovarian Cancer View
None Lung Adenocarcinoma View
None Endometrial Cancer View